- Home
- AIM vs MKDW Comparison
AIM vs MKDW Comparison
Compare AIM & MKDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIM
- MKDW
- Stock Information
- Founded
- AIM 1966
- MKDW 2006
- Country
- AIM United States
- MKDW Taiwan
- Employees
- AIM N/A
- MKDW N/A
- Industry
- AIM Biotechnology: Biological Products (No Diagnostic Substances)
- MKDW
- Sector
- AIM Health Care
- MKDW
- Exchange
- AIM Nasdaq
- MKDW NYSE
- Market Cap
- AIM 8.8M
- MKDW 8.5M
- IPO Year
- AIM N/A
- MKDW N/A
- Fundamental
- Price
- AIM $0.12
- MKDW $0.26
- Analyst Decision
- AIM Strong Buy
- MKDW
- Analyst Count
- AIM 2
- MKDW 0
- Target Price
- AIM $2.75
- MKDW N/A
- AVG Volume (30 Days)
- AIM 476.8K
- MKDW 177.5K
- Earning Date
- AIM 03-27-2025
- MKDW 12-31-2024
- Dividend Yield
- AIM N/A
- MKDW N/A
- EPS Growth
- AIM N/A
- MKDW N/A
- EPS
- AIM N/A
- MKDW N/A
- Revenue
- AIM $170,000.00
- MKDW $3,670,722.00
- Revenue This Year
- AIM N/A
- MKDW N/A
- Revenue Next Year
- AIM $1,693.10
- MKDW N/A
- P/E Ratio
- AIM N/A
- MKDW N/A
- Revenue Growth
- AIM N/A
- MKDW 16.40
- 52 Week Low
- AIM $0.11
- MKDW $0.26
- 52 Week High
- AIM $0.62
- MKDW $16.00
- Technical
- Relative Strength Index (RSI)
- AIM 42.13
- MKDW N/A
- Support Level
- AIM $0.11
- MKDW N/A
- Resistance Level
- AIM $0.16
- MKDW N/A
- Average True Range (ATR)
- AIM 0.01
- MKDW 0.00
- MACD
- AIM 0.00
- MKDW 0.00
- Stochastic Oscillator
- AIM 5.00
- MKDW 0.00
About AIM AIM ImmunoTech Inc.
AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases, and the drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer, and triple-negative metastatic breast cancer. It is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.